Abstract:Foot-and-mouth disease (FMD) is a contagious viral disease of livestock with significant economic effect. It is prevalent in various regions of Asia, Africa, and South America. The causative agent of this disease is called foot-and-mouth disease virus (FMDV), which is a member of Aphthovirus genus. Vaccination is an effective technique to prevent the complications of FMD and to eradicate the disease in contaminated regions. Attempts are being made since the 1930s to develop potent vaccines against FMD. The history of vaccination against FMD has documented various types of vaccines including inactivated viruses and empty capsids, as well as attenuated and recently developed recombinant vaccines. Although the available inactivated virus vaccines effectively prevent FMD, they have several limitations such as expensiveness, short shelf life, and short-lived protection. Therefore, it is essential to provide other types of vaccine. To reach this goal, researchers used various platforms including bacterial hosts, yeast expression system, and mammalian cell culture, as well as microalgae and higher plants to produce recombinant vaccines against FMDV. Green plants offer numerous benefits including low cost, correctly folded recombinant, and improved glycosylation patterns. This study aimed to provide a review of the current status and recent progress in the field of producing effective vaccines against FMDV entailing empty capsid, attenuated vaccines, and recombinant subunit vaccines. In addition, the advantages and disadvantages of each type are described, and the biotechnological improvements of the production of anti-FMD vaccines in plant systems are discussed with prominent examples, thereby confirming the feasibility of plant species as effective bioreactors for the production of recombinant vaccines. To the best of our knowledge, traditional approaches are still the preferred methods to protect livestock against FMD. Modern approaches such as recombinant vaccine production are quite promising. However, they have to pass research and development phase and further trials before they can be registered and launched onto the relevant market.

Cloning and expression of a novel synthetic gene containing VP1 and 3A in Bacillus subtilis as a vaccine candidate against foot-and-mouth disease virus

Prokaryotic Expression of Structural Protein VP1 of Foot-and-mouth disease virus Type O and Analysis of Its Antigenicity

Development of Tobacco necrosis virus A as a vector for efficient and stable expression of FMDV VP1 peptides.

Expression and immunogenicity of recombinant fusion protein comprising foot-and-mouth disease virus structural protein VP1 and intercellular adhesion molecule ICAM-2

A Novel Mucosal Vaccine Against Foot-and-Mouth Disease Virus Induces Protection in Mice and Swine

A novel immunoinformatics approach for developing a poly-epitope vaccine targeting foot and mouth disease virus, exploiting structural VP proteins

Characterisation of capsid polypeptide P1 and capsid protein VP1 of the Malaysia foot and mouth disease virus (FMDV) serotype O and A isolates

Developing Vaccines Against Foot-and-Mouth Disease: a Biotechnological Approach

Preparation and Characterization of Nanoliposome Containing Isolated VP1 Protein of Foot and Mouth Disease Virus as a Model of Vaccine.

Development of recombinant vp1 protein immunised in mice as a model of foot-and-mouth disease vaccine

High-level expression of codon optimized foot-and-mouth disease virus complex epitopes and cholera toxin B subunit chimera in Hansenula polymorpha.

Recombinant vesicular stomatitis virus glycoprotein carrying a foot-and-mouth disease virus epitope as a vaccine candidate

Genetic and Antigenic Evaluation of Foot-and-mouth Disease Virus Type A in the Endemic Area of Iran within 2014-2015

Biotechnological approach to a new foot-and-mouth disease virus vaccine

Oral immunization against foot-and-mouth disease virus using recombinant Saccharomyces cerevisiae with the improved expression of the codon-optimized VP1 fusion protein

Protective Immune Responses Against Foot-And-Mouth Disease Virus by Vaccination with A Dna Vaccine Expressing Virus-Like Particles

Immune potential of a novel multiple-epitope vaccine to FMDV type Asia 1 in guinea pigs and sheep

Prokaryotic Expression and Activity Analysis of VP1 Gene of Foot-and-Mouth Disease Virus Serotype O

Immunogenicity analysis of the E. coli expressed structural protein VP1 of persistent infection foot-and-mouth disease virus

Efficacy of a Novel Multiepitope Vaccine Candidate against Foot-and-Mouth Disease Virus Serotype O and A

Design and Construction of Multiple-Epitope Recombinant Vaccine Against Foot-and-Mouth Disease Virus Type O